Atlas Trials

A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma

Clinical trial NCT02978235 · TERMINATED

Trial details

NCT number
NCT02978235
Sponsor
Taiho Oncology, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple MyelomaNonHodgkin Lymphoma
Start date
2017-03-01
Primary completion
2018-02-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.